Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer’s disease

To determine the utility of subjective memory decline (SMD) to predict episodic memory change and rates of clinical progression in cognitively normal older adults with evidence of high β-amyloid burden (CN Aβ+).

from Dementia Big http://ift.tt/1Pa8hut
via Stopping Dementia

from WordPress http://ift.tt/1obDy7s
via alcoholic dementia
http://ift.tt/1X7kG5s